retatrutide trial news from TRIUMPH-1, a Phase 3 of retatrutide, the first-in-class GIP/GLP-1/GCGR agonist investigating the effect of adding glucagon receptor activation on top of the dual mechanism of… Trial of next-gen weight-loss drug

We suggested that energy metabolism is upregulated across multiple immune compartments in both ABMR and TCMR samples: proliferating T cells, CTLax.3

Related resources In case I dont see you, good afternoon, good evening, and good night

Neuroprotective levels of IGF-1 exacerbate epileptogenesis after brain injury [PMID: 27561791] Laboratory literature summary: Neuroprotective levels of IGF-1 exacerbate epileptogenesis after brain injury

Key contributors include urbanization, an aging population, decreasing levels of physical activity, and increased levels of overweight and obesity

Indian approval conditions are explicit: Mounjaro and Novo Nordisks Wegovy are to be dispensed only on the prescription of an endocrinologist or an internal medicine specialist